Picture of Alk-Abello A/S logo

ALK B — Alk-Abello A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

ALK-Abello heads for best day in 14 years after Q3 earnings beat

** Shares in ALK-Abello  ALKb.CO  jump around 16% after the
Danish pharmaceutical company's Q3 earnings beat expectations
thanks to sales growth, gross margin improvement, and a modest
decline in capacity costs
    ** Q3 EBIT jumped 128% in local currencies to DKK 147
million ($21.43 million), total revenue was up by 8% to DKK
1,110 million  
    ** ALK-Abello maintained its FY outlook 
    ** Sydbank says the company's turnover met the market's
expectations, while Q3 EBIT beat the expected DKK 104 million   
 
    ** If gains hold, the stock will see its best day since 2009


($1 = 6.8585 Danish crowns)

 (Reporting by Marta Frąckowiak)
 ((marta.frackowiak@thomsonreuters.com))

Recent news on Alk-Abello A/S

See all news